The 36-month beta value for CLVT is also noteworthy at 1.16. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for CLVT is 413.64M, and at present, short sellers hold a 10.44% of that float. The average trading volume of CLVT on January 14, 2025 was 5.36M shares.
CLVT) stock’s latest price update
The stock of Clarivate Plc (NYSE: CLVT) has increased by 0.79 when compared to last closing price of 5.07.Despite this, the company has seen a gain of 0.20% in its stock price over the last five trading days. prnewswire.com reported 2025-01-08 that Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to redefine the future of healthcare. This year, the highly anticipated resource highlights 11 drugs projected to achieve blockbuster status or revolutionize treatment paradigms within five years.
CLVT’s Market Performance
Clarivate Plc (CLVT) has experienced a 0.20% rise in stock performance for the past week, with a -6.24% drop in the past month, and a -24.30% drop in the past quarter. The volatility ratio for the week is 3.55%, and the volatility levels for the past 30 days are at 3.94% for CLVT. The simple moving average for the past 20 days is -0.14% for CLVT’s stock, with a -16.86% simple moving average for the past 200 days.
Analysts’ Opinion of CLVT
Wells Fargo, on the other hand, stated in their research note that they expect to see CLVT reach a price target of $8. The rating they have provided for CLVT stocks is “Underweight” according to the report published on December 15th, 2023.
Jefferies gave a rating of “Buy” to CLVT, setting the target price at $8.50 in the report published on October 16th of the previous year.
CLVT Trading at -3.55% from the 50-Day Moving Average
After a stumble in the market that brought CLVT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.80% of loss for the given period.
Volatility was left at 3.94%, however, over the last 30 days, the volatility rate increased by 3.55%, as shares sank -5.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.75% lower at present.
During the last 5 trading sessions, CLVT rose by +0.20%, which changed the moving average for the period of 200-days by -30.38% in comparison to the 20-day moving average, which settled at $5.12. In addition, Clarivate Plc saw 0.59% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLVT starting from Angelakis Michael J, who purchase 1,500,000 shares at the price of $5.11 back on Nov 20 ’24. After this action, Angelakis Michael J now owns 1,500,000 shares of Clarivate Plc, valued at $7,665,000 using the latest closing price.
Angelakis Michael J, the Director of Clarivate Plc, purchase 1,200,000 shares at $5.19 during a trade that took place back on Nov 21 ’24, which means that Angelakis Michael J is holding 2,700,000 shares at $6,228,000 based on the most recent closing price.
Stock Fundamentals for CLVT
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.52 for the gross margin
The net margin for Clarivate Plc stands at -0.5. The total capital return value is set at 0.02. Equity return is now at value -21.14, with -10.13 for asset returns.
Based on Clarivate Plc (CLVT), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.15. The debt to equity ratio resting at 0.84. The interest coverage ratio of the stock is 0.64.
Currently, EBITDA for the company is -10.5 million with net debt to EBITDA at -16.58. When we switch over and look at the enterprise to sales, we see a ratio of 3.09. The receivables turnover for the company is 3.34for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
In summary, Clarivate Plc (CLVT) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
